Healthcare-Associated Infections (HAIs) represent a huge burden of AMR in the developed world. Unfortunately, most drugs available to treat serious infections caused by gram-negative bacteria can only be administered intravenously as one or more of the active compounds has poor oral bioavailability.

The ASM/ESCMID Conference on Drug Development returns to Boston, Massachusetts for 2019. Check back soon for program details.

This is the perfect platform to generate new leads, create brand awareness and launch new products. No other marketing gets you in a room with so many potential customers looking for suppliers.